<DOC>
	<DOCNO>NCT02042690</DOCNO>
	<brief_summary>The survival adult patient standard-risk acute lymphoblastic leukemia ( ALL ) need improve . We want compare efficacy haplo-identical hematopoietic stem cell transplantation ( HSCT ) chemotherapy adult ( age:18-39 year old ) ALL patient first phase complete remission ( CR1 )</brief_summary>
	<brief_title>Haplo-identical HSCT Versus Chemotherapy Adult Acute Lymphoblastic Leukemia Patients</brief_title>
	<detailed_description>Although high complete remission rate ( 80 % -90 % ) achieve , long-term survival rate standard-risk adult patient acute lymphoblastic leukemia ( ALL ) 25 % -55 % receive chemotherapy alone . The survival rate improve uo 50 % -75 % receive HLA-matched HSCT However , chance find HLA-matched donor low , especially China . Alternative donor halpo-identical relate donor might choice . Our retrospective analysis show 59 % overall survival could achieve standard-risk adult ALL patient receive halpo-identical HSCT.Therefore , start randomization control trial compare efficacy haplo-identical HSCT chemotherapy adult ( age:18-39 year old ) ALL patient CR1 .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>acute lymphoblastic leukemia 1839 year old first complete remission Adequate hepatic function define : total bilirubin ≤2.0 time institutional upper limit normal ( ULN ) ; alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≤2.5 time institutional ULN Adequate renal function define creatinine ≤3 time institutional ULN No uncontrollable infection Performance Status ( PS ) score 02 ( WHO ) Subjects able provide write informed consent HLAmatched donor highrisk ALL : ( 1 ) Ph+ALL ( 2 ) Hypodiploidy ( 3 ) ( v ; 11q23 ) ( 4 ) complex karyotype（≥5 chromosome abnormalities）（5）high white blood cell ( WBC ) count ( BALL≥30×109/L ; TALL ≥100×109/L ) . pregnancy Loss ability freely provide consent due psychiatric physical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Acute Lymphoblastic Leukemia</keyword>
	<keyword>hematopoietic stem cell transplantation</keyword>
	<keyword>chemotherapy</keyword>
</DOC>